By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioCon Limited 

20th KM Hosur Road

Electronics City  Bangalore  560 100  India
Phone: 90-80-2808-2808 Fax: 91-80-2852-3423



Company News
Mylan (MYL) And BioCon (BIOCON.NS) Announce Regulatory Submission For Proposed Biosimilar Pegfilgrastim Accepted For Review By European Medicines Agency 7/21/2016 9:50:41 AM
BioCon (BIOCON.NS), Quark Pharmaceuticals Inc. Announce Initiation Of Pivotal Phase II/III Study Of QPI-1007 In Rare Eye Disease In India 6/23/2016 6:09:02 AM
ASCO2016: Mylan (MYL)-BioCon (BIOCON.NS)'s Biosimilar Cancer Drug Comparable to Roche (RHHBY)'s Herceptin 6/6/2016 7:38:00 AM
BioCon Limited (BIOCON.NS) Gears Up For US Generics Push 8/7/2015 7:28:01 AM
Industry Titans BioCon Limited (BIOCON.NS), PBOA, Biotec Services And Pharmatech Associates Join CPhI Annual Report For 2015 7/16/2015 2:50:03 PM
Dr. Jeremy Levin & Prof. (Dr.) Vijay Kuchroo Join BioCon Limited (BIOCON.NS)’s Board Of Directors 1/30/2015 7:43:17 AM
BioCon Limited (BIOCON.NS) Expands Its Strategic Partnership With CytoSorbents, Inc. For Cytosorb® To Treat SIRS And Cardiac Surgery Patients 11/3/2014 8:31:56 AM
Haselmeier GmbH Announces the Launch Of INSUPen® EZ In India By BioCon Limited (BIOCON.NS) 10/27/2014 11:20:04 AM
BioCon Limited (BIOCON.NS) Collaborates With Advaxis, Inc. For "ADXS-HPV" A Novel Cancer Immunotherapy 1/22/2014 8:37:53 AM
BioCon Limited (BIOCON.NS) Hits Roche (RHHBY) First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin 1/20/2014 8:08:38 AM